Home › European Commission approves EYLEA Injection for treatment of visual impairment due to DME
 

Keywords :   


European Commission approves EYLEA Injection for treatment of visual impairment due to DME

2014-08-11 12:16:33| Biotech - Topix.net

Regeneron Pharmaceuticals, Inc. today announced that EYLEA Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema .

Tags: to due treatment visual

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Digital video subscriptions to reach 3.5 billion by 2028
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
More »